Avalyn Pharma Inc (AVLN)
NASDAQ:AVLN
Want to see AVLN full AI Analyst Report?
AVLN Stock Chart & Stats
$28.84
$0.43(1.51%)
―
--
Day’s Range― - ―
52-Week Range$25.05 - $32.23
Previous CloseN/A
VolumeN/A
Average Volume (3M)931.19K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-7.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,812,046
10 Day Avg. Volume383,220
30 Day Avg. Volume931,186
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVLN FAQ
What was Avalyn Pharma Inc’s price range in the past 12 months?
Avalyn Pharma Inc lowest stock price was $25.05 and its highest was $32.23 in the past 12 months.
What is Avalyn Pharma Inc’s market cap?
Currently, no data Available
When is Avalyn Pharma Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Avalyn Pharma Inc’s earnings last quarter?
Currently, no data Available
Is Avalyn Pharma Inc overvalued?
According to Wall Street analysts Avalyn Pharma Inc’s price is currently Undervalued.
Does Avalyn Pharma Inc pay dividends?
Avalyn Pharma Inc does not currently pay dividends.
What is Avalyn Pharma Inc’s EPS estimate?
Avalyn Pharma Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Avalyn Pharma Inc have?
Avalyn Pharma Inc has 41,812,046 shares outstanding.
What happened to Avalyn Pharma Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Avalyn Pharma Inc?
Currently, no hedge funds are holding shares in AVLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Avalyn Pharma Inc
Avalyn Pharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). The company was founded by Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar on May 27, 2011 and is headquartered in Boston, MA.
Ownership Overview
Options Prices
Currently, No data available
---